Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies
Ahmed L. Al-Mashhadi, Mikkel R. Simonsen, Elizabeth Smyth, Rose-Marie Amini, Bente Arboe, James R. Cerhan, Iman Chanchiri, Chan Y. Cheah, Jonathan R. Day, Toby A. Eyre, Anne O. Gang, Herve Ghesquieres, Thomas M. Habermann, Eliza Hawkes, Steven Hwang, Ruxandra Irimia, Jennifer B. Jørgensen, Arushi Khurana, Claire Maquet, Matthew Maurer, Lay She Ng, Stephen Opat, Martin B. Pedersen, Christian B. Poulsen, Alexandros Rampotas, Andreea Sima, Karin E. Smedby, Knut B. Smeland, Gita Thanarajasingam, Jud Blood Cancer Journal
· Springer Nature
· 2026-11-09
· DOI: 10.1038/s41408-026-01660-2
Аннотация
Blood Cancer Journal, Published online: 09 November 2026; doi:10.1038/s41408-026-01660-2 Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies
Ahmed L. Al-Mashhadi, Mikkel R. Simonsen, Elizabeth Smyth, Rose-Marie Amini, Bente Arboe, James R. Cerhan et al. Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies. // Blood Cancer Journal. – 2026. – DOI: 10.1038/s41408-026-01660-2. – URL: https://www.nature.com/articles/s41408-026-01660-2
Ahmed L. Al-Mashhadi, Mikkel R. Simonsen, Elizabeth Smyth, Rose-Marie Amini, Bente Arboe, James R. Cerhan, Iman Chanchiri, Chan Y. Cheah, Jonathan R. Day, Toby A. Eyre, Anne O. Gang, Herve Ghesquieres, Thomas M. Habermann, Eliza Hawkes, Steven Hwang, Ruxandra Irimia, Jennifer B. Jørgensen, Arushi Khurana, Claire Maquet, Matthew Maurer, Lay She Ng, Stephen Opat, Martin B. Pedersen, Christian B. Poulsen, Alexandros Rampotas, Andreea Sima, Karin E. Smedby, Knut B. Smeland, Gita Thanarajasingam, & Jud (2026). Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01660-2
Ahmed L. Al-Mashhadi, et al. “Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies.” Blood Cancer Journal, 2026. doi:10.1038/s41408-026-01660-2.
@article{AlMashhadi2026,
title = {Clinical characteristics, treatment, and long-term outcomes in 987 patients with splenic marginal zone lymphoma to inform treatment and surveillance strategies},
author = {Al-Mashhadi, Ahmed L. and Simonsen, Mikkel R. and Smyth, Elizabeth and Amini, Rose-Marie and Arboe, Bente and Cerhan, James R. and Chanchiri, Iman and Cheah, Chan Y. and Day, Jonathan R. and Eyre, Toby A. and Gang, Anne O. and Ghesquieres, Herve and Habermann, Thomas M. and Hawkes, Eliza and Hwang, Steven and Irimia, Ruxandra and Jørgensen, Jennifer B. and Khurana, Arushi and Maquet, Claire and Maurer, Matthew and Ng, Lay She and Opat, Stephen and Pedersen, Martin B. and Poulsen, Christian B. and Rampotas, Alexandros and Sima, Andreea and Smedby, Karin E. and Smeland, Knut B. and Thanarajasingam, Gita and Jud},
journal = {Blood Cancer Journal},
year = {2026},
doi = {10.1038/s41408-026-01660-2},
url = {https://www.nature.com/articles/s41408-026-01660-2}
}